The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
The pathogenesis of Epstein–Barr virus persistent infection
Open accessAbstract
Epstein-Barr virus (EBV) maintains a lifelong infection. According to the germinal center model (GCM), latently infected B cells transit the germinal center (GC) to become resting memory cells. Here, the virus resides quiescently, occasionally reactivating to infect new B cells, completing the cycle of infection. The GCM remains the only model that explains EBV biology and the pathogenesis of lymphoma. Recent work suggests modifications to the model notably that the virus contributes only modestly to the GC process and predictions from mathematical models that quiescence within memory B cells shapes the overall structure of viral infection but is not essential for persistence. Rather, it is the cycle of infection which allows viral persistence at the very low levels observed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epstein-Barr virus and its replication
Kieff, E. D. (1996) · Medical Entomology and Zoology · Cited by 1,627
Persistence of the Epstein–Barr Virus and the Origins of Associated Lymphomas
Thorley-Lawson, D. A., & Gross, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032015 · Cited by 1,054
Self-citationEpstein-Barr virus: exploiting the immune system
Thorley-Lawson, D. A. (2001) · Nature Reviews Immunology · doi:10.1038/35095584 · Cited by 939
Self-citationEBV Persistence in Memory B Cells In Vivo
Babcock, G. J., Decker, L. L., Volk, M., & Thorley-Lawson, D. A. (1998) · Immunity · doi:10.1016/s1074-7613(00)80622-6 · Cited by 825
Self-citationCellular responses to viral infection in humans: lessons from Epstein–Barr virus
Hislop, A. D., Taylor, G. S., Sauce, D., & Rickinson, A. B. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141553 · Cited by 766
Caldwell, R. G., Wilson, J. B., Anderson, S. J., & Longnecker, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80623-8 · Cited by 597
B cell receptor signal strength determines B cell fate
Casola, S., Otipoby, K. L., Alimzhanov, M., Humme, S., Uyttersprot, N., Kutok, J. L., Carroll, M. C., & Rajewsky, K. (2004) · Nature Immunology · doi:10.1038/ni1036 · Cited by 568
Laichalk, L. L., & Thorley-Lawson, D. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.1296-1307.2005 · Cited by 538
Self-citationMurray, R. J., Kurilla, M. G., Brooks, J. M., Thomas, W. A., Rowe, M., Kieff, E., & Rickinson, A. B. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.1.157 · Cited by 499
Babcock, G. J., Hochberg, D., & Thorley‐Lawson, D. A. (2000) · Immunity · doi:10.1016/s1074-7613(00)00049-2 · Cited by 481
Self-citationLatent membrane protein 1of Epstein-Barr virus mimics a constitutively active receptor molecule
Gires, O. (1997) · The EMBO Journal · doi:10.1093/emboj/16.20.6131 · Cited by 451
Mimicry of CD40 Signals by Epstein-Barr Virus LMP1 in B Lymphocyte Responses
Uchida, J., Yasui, T., Takaoka-Shichijo, Y., Muraoka, M., Kulwichit, W., Raab-Traub, N., & Kikutani, H. (1999) · Science · doi:10.1126/science.286.5438.300 · Cited by 437
Victora, G. D., Dominguez-Sola, D., Holmes, A. B., Deroubaix, S., Dalla-Favera, R., & Nussenzweig, M. C. (2012) · Blood · doi:10.1182/blood-2012-03-415380 · Cited by 411
Hochberg, D., Middeldorp, J. M., Catalina, M., Sullivan, J. L., Luzuriaga, K., & Thorley-Lawson, D. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2237267100 · Cited by 279
Self-citationEpstein-Barr virus provides a survival factor to Burkitt's lymphomas
Kennedy, G., Komano, J., & Sugden, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336099100 · Cited by 276
He, B., Raab-Traub, N., Casali, P., & Cerutti, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5215 · Cited by 247
EBV-Infected B Cells in Infectious Mononucleosis
Kurth, J., Spieker, T., Wustrow, J., Strickler, J. G., Hansmann, M.-L., Rajewsky, K., & Küppers, R. (2000) · Immunity · doi:10.1016/s1074-7613(00)00048-0 · Cited by 226
Seto, E., Moosmann, A., Grömminger, S., Walz, N., Grundhoff, A., & Hammerschmidt, W. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001063 · Cited by 220
The Epstein–Barr Virus BART microRNAs target the pro-apoptotic protein Bim
Marquitz, A. R., Mathur, A., Nam, C. S., & Raab-Traub, N. (2011) · Virology · doi:10.1016/j.virol.2011.01.028 · Cited by 194
Epstein–Barr virus maintains lymphomas via its miRNAs
Vereide, D. T., Seto, E., Chiu, Y.-F., Hayes, M., Tagawa, T., Grundhoff, A., Hammerschmidt, W., & Sugden, B. (2014) · Oncogene · doi:10.1038/onc.2013.71 · Cited by 171
Pudney, V. A., Leese, A. M., Rickinson, A. B., & Hislop, A. D. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041542 · Cited by 158
A Novel Persistence Associated EBV miRNA Expression Profile Is Disrupted in Neoplasia
Qiu, J. J., Cosmopoulos, K., Pegtel, D. M., Hopmans, E. S., Murray, P. G., Middeldorp, J. M., Shapiro, M., & Thorley‐Lawson, D. A. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002193 · Cited by 141
Self-citationSouza, T. A., Stollar, B. D., Sullivan, J. L., Luzuriaga, K., & Thorley‐Lawson, D. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509311102 · Cited by 121
Self-citationPersistence of Epstein-Barr Virus in Self-Reactive Memory B Cells
Tracy, S. I., Kakalacheva, K., Lünemann, J. D., Luzuriaga, K., Middeldorp, J. M., & Thorley‐Lawson, D. A. (2012) · Journal of Virology · doi:10.1128/jvi.01699-12 · Cited by 107
Self-citationRoughan, J. E., Torgbor, C., & Thorley‐Lawson, D. A. (2009) · Journal of Virology · doi:10.1128/jvi.01780-09 · Cited by 84
Self-citationHeath, E. M., Pastor, N. B., Chaganti, S., Croom-Carter, D. S. G., Shannon-Lowe, C. D., Kube, D., Feederle, R., Delecluse, H., Rickinson, A. B., & Bell, A. I. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002697 · Cited by 77
Chaganti, S., Heath, E. M., Bergler, W. F., Kuo, M., Buettner, M. J., Niedobitek, G., Rickinson, A. B., & Bell, A. I. (2009) · Blood · doi:10.1182/blood-2008-08-175828 · Cited by 66
EBV transformation overrides gene expression patterns of B cell differentiation stages
Siemer, D., Kurth, J., Lang, S., Lehnerdt, G., Stanelle, J., & Küppers, R. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.03.002 · Cited by 54
Chaganti, S., Ma, C. S., Bell, A. I., Croom-Carter, D. S. G., Hislop, A. D., Tangye, S. G., & Rickinson, A. B. (2008) · Blood · doi:10.1182/blood-2007-10-116269 · Cited by 53
A virtual look at Epstein–Barr virus infection: Simulation mechanism
Shapiro, M., Duca, K., Lee, K., Delgado‐Eckert, E., Hawkins, J. B., Jarrah, A. S., Laubenbacher, R., Polys, N. F., Hadinoto, V., & Thorley‐Lawson, D. A. (2008) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2008.01.032 · Cited by 40
Self-citation
Cited by
The Immunology of Epstein-Barr Virus–Induced Disease
Taylor, G. S., Long, H. M., Brooks, J. M., Rickinson, A. B., & Hislop, A. D. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112326 · Cited by 602
Epstein–Barr virus-associated lymphomas
Shannon-Lowe, C., Rickinson, A. B., & Bell, A. I. (2017) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2016.0271 · Cited by 428
Human T Cell Aging and the Impact of Persistent Viral Infections
Fülöp, T., Larbi, A., & Pawelec, G. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00271 · Cited by 347
The role of Epstein–Barr virus in epithelial malignancies
Tsao, S., Tsang, C. M., To, K., & Lo, K. (2015) · The Journal of Pathology · doi:10.1002/path.4448 · Cited by 337
EBV Persistence—Introducing the Virus
Thorley-Lawson, D. A. (2015) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-319-22822-8_8 · Cited by 333
Self-citation
Metadata
- Authors
- Thorley-Lawson, D. A., Hawkins, J. B., Tracy, S. I., & Shapiro, M.
- Venue
- Current Opinion in Virology
- Publisher
- Elsevier BV
- Published
- 2013-06
- Volume
- 3
- Issue
- 3
- Pages
- 227-232
- ISSN
- 1879-6257 (ISSN-L)
- OpenAlex
- W2025042617
- Cited by
- 254
- References
- 30
- FWCI
- 2.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.